Related Experiment Videos
Feedback mechanism in sulpiride-induced hyperprolactinaemia.
British Journal of Obstetrics and Gynaecology
|April 1, 1983
Summary
Estrogen feedback on luteinizing hormone (LH) release remains effective in women with hyperprolactinemia, even when induced by sulpiride. This study confirms estrogen
Area of Science:
- Reproductive Endocrinology
- Neuroendocrinology
Background:
- Hyperprolactinemia, often caused by medications like sulpiride, can disrupt normal reproductive hormone cycles.
- Understanding the impact of hyperprolactinemia on the feedback mechanisms of reproductive hormones is crucial for reproductive health.
Purpose of the Study:
- To investigate the estrogen feedback effect on gonadotropin release in women with varying levels of hyperprolactinemia.
- To determine if the estrogen feedback mechanism is preserved in women experiencing sulpiride-induced hyperprolactinemia.
Main Methods:
- Serum concentrations of prolactin, luteinizing hormone (LH), follicle-stimulating hormone (FSH), and estradiol were measured using radioimmunoassay.
- Ethinyl estradiol was administered orally to induce a controlled hormonal response in participants.
Main Results:
- Oral ethinyl estradiol administration resulted in an initial decrease followed by a significant rebound peak in LH levels.
- Follicle-stimulating hormone (FSH) levels showed an initial decrease with a minor rebound, while estradiol levels decreased during treatment.
- The estrogen feedback effect on LH release was observed to be maintained in both normally cycling women and those with sulpiride-induced hyperprolactinemia.
Conclusions:
- Estrogen's feedback effect on luteinizing hormone (LH) release is preserved in women with sulpiride-induced hyperprolactinemia.
- These findings suggest that hormonal interventions targeting estrogen feedback may be viable in managing reproductive disturbances associated with hyperprolactinemia.